|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/551 | (2006.01) |
| A61K 31/506 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/12 | (2006.01) |
| (11) | Number of the document | 2111863 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09007232.3 |
| Date of filing the European patent application | 2006-10-25 | |
| (97) | Date of publication of the European application | 2009-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2012-03-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 730273 P | 2005-10-26 | US |
| (72) |
Fong, Benson, US
|
| (73) |
Asahi Kasei Pharma Corporation,
1-105 Kanda Jinbocho Chiyoda-ku, Tokyo 101-8101,
JP
|
| (54) | Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension |
| Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension |